Changes in targeted therapy and costs in NSCLC between 2009 and 2013

J. Walter (Neuherberg, Germany), R. Holle (Neuherberg, Germany), A. Tufman (München, Germany), L. Schwarzkopf (Neuherberg, Germany)

Source: International Congress 2018 – Lung cancer: personalised medicine
Session: Lung cancer: personalised medicine
Session type: Poster Discussion
Number: 2216
Disease area: Thoracic oncology

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Walter (Neuherberg, Germany), R. Holle (Neuherberg, Germany), A. Tufman (München, Germany), L. Schwarzkopf (Neuherberg, Germany). Changes in targeted therapy and costs in NSCLC between 2009 and 2013. 2216

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: